Skip to main content
Erschienen in: Medical Oncology 2/2010

01.06.2010 | Original Paper

Increased incidence of papillary thyroid microcarcinoma with decreased tumor size of thyroid cancer

verfasst von: Jen-Der Lin

Erschienen in: Medical Oncology | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

The prevalence of papillary thyroid microcarcinoma (PTMC) in thyroid cancer varies from 20.0% to 42.8% with a mean of 30.0%. Most of these patients have benign clinical courses and receive less aggressive therapeutic procedures in most medical centers. This study retrospectively reviewed 30 years data in one institute and compared it with recent publications to illustrate change in trends and influence of PTMC. Incidental PTMC is usually diagnosed as a postoperative microcarcinoma following thyroidectomy for presumably benign thyroid lesions. Subtotal thyroidectomy or lobectomy without radioactive iodide treatment is sufficient to treat incidental PTMC. In contrast, aggressive surgical treatment with 131I therapy is indicated for non-incidental PTMC. Those with PTMC in the absence of extra-thyroid invasion diagnosed by postoperative permanent section received follow-up if they had initially received subtotal thyroidectomy. In long-term follow-up studies, cancer-specific mortality for PTMC ranged from 0% to 4%. Most of the mortality cases had distant metastasis at the time of surgery. The clinical course and therapeutic strategies for the non-incidental PTMC patients depend on the TNM stage at the time of diagnosis. One-third of PTMC with clinically aggressive behavior cannot be treated as indolent disease. Invasive tumor markers or larger tumor size are useful to predict tumor recurrence or distant metastasis for PTMC.
Literatur
3.
Zurück zum Zitat Gerard AC, et al. Relationships between cell division, expression of growth factors and microcirculation in the thyroids of Tg-A2aR transgenic mice and patients with Graves’ disease. J Endocrinol. 2003;177:269–77. doi:10.1677/joe.0.1770269.CrossRefPubMed Gerard AC, et al. Relationships between cell division, expression of growth factors and microcirculation in the thyroids of Tg-A2aR transgenic mice and patients with Graves’ disease. J Endocrinol. 2003;177:269–77. doi:10.​1677/​joe.​0.​1770269.CrossRefPubMed
6.
Zurück zum Zitat Howlett DC, Speirs A. The thyroid incidentaloma—ignore or investigate? J Ultrasound Med. 2007;26:1367–71.PubMed Howlett DC, Speirs A. The thyroid incidentaloma—ignore or investigate? J Ultrasound Med. 2007;26:1367–71.PubMed
10.
Zurück zum Zitat Sobin LH, UICC. In: Wittekind Ch, editor. TNM classification of malignant tumors. 6th ed. New York: Wiley-Liss; 2002. p. 52–6. Sobin LH, UICC. In: Wittekind Ch, editor. TNM classification of malignant tumors. 6th ed. New York: Wiley-Liss; 2002. p. 52–6.
13.
14.
Zurück zum Zitat Rossi R, et al. Differentiated thyroid cancers 11–20 mm in diameter have clinical and histopathologic characteristics suggesting higher aggressiveness than those < or = 10 mm. Thyroid. 2008;18:309–15. doi:10.1089/thy.2007.0100.CrossRefPubMed Rossi R, et al. Differentiated thyroid cancers 11–20 mm in diameter have clinical and histopathologic characteristics suggesting higher aggressiveness than those < or = 10 mm. Thyroid. 2008;18:309–15. doi:10.​1089/​thy.​2007.​0100.CrossRefPubMed
16.
Zurück zum Zitat Delellis RA, Lloyd RV, Heitx PU, et al. Pathology and genetics of tumors of endocrine organs. In: World Health Organization of tumours. IARC, Lyon; 2004. pp. 73–6. Delellis RA, Lloyd RV, Heitx PU, et al. Pathology and genetics of tumors of endocrine organs. In: World Health Organization of tumours. IARC, Lyon; 2004. pp. 73–6.
17.
Zurück zum Zitat DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 1990;71:414–24.CrossRefPubMed DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 1990;71:414–24.CrossRefPubMed
18.
Zurück zum Zitat Deveci MS, Deveci G, LiVolsi VA, Gupta PK, Baloch ZW. Concordance between thyroid nodule sizes measured by ultrasound and gross pathology examination: effect on patient management. Diagn Cytopathol. 2007;35:579–83. doi:10.1002/dc.20714.CrossRefPubMed Deveci MS, Deveci G, LiVolsi VA, Gupta PK, Baloch ZW. Concordance between thyroid nodule sizes measured by ultrasound and gross pathology examination: effect on patient management. Diagn Cytopathol. 2007;35:579–83. doi:10.​1002/​dc.​20714.CrossRefPubMed
20.
Zurück zum Zitat Lissak B, Vannetzel JM, Gallouedec N, Berrod JL, Rieu M. Solitary skin metastasis as the presenting feature of differentiated thyroid microcarcinoma: report of two cases. J Endocrinol Invest. 1995;18:813–6.PubMed Lissak B, Vannetzel JM, Gallouedec N, Berrod JL, Rieu M. Solitary skin metastasis as the presenting feature of differentiated thyroid microcarcinoma: report of two cases. J Endocrinol Invest. 1995;18:813–6.PubMed
21.
Zurück zum Zitat Russo F, et al. Clinico-pathological study of microcarcinoma of the thyroid. Minerva Chir. 1997;52:891–900.PubMed Russo F, et al. Clinico-pathological study of microcarcinoma of the thyroid. Minerva Chir. 1997;52:891–900.PubMed
26.
Zurück zum Zitat Roti E, et al. Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab. 2006;91:2043–6. doi:10.1210/jc.2005-2372.CrossRef Roti E, et al. Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab. 2006;91:2043–6. doi:10.​1210/​jc.​2005-2372.CrossRef
27.
Zurück zum Zitat Hay ID, et al. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery. 1992;112:1139–46.PubMed Hay ID, et al. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery. 1992;112:1139–46.PubMed
28.
Zurück zum Zitat Rodriguez JM, et al. Papillary thyroid microcarcinoma: clinical study and prognosis. Eur J Surg. 1997;163:255–9.PubMed Rodriguez JM, et al. Papillary thyroid microcarcinoma: clinical study and prognosis. Eur J Surg. 1997;163:255–9.PubMed
32.
Zurück zum Zitat Kini S, et al. Occult medullary carcinoma of thyroid with lymph node metastases: a case report. Acta Cytol. 2008;52:105–8.PubMed Kini S, et al. Occult medullary carcinoma of thyroid with lymph node metastases: a case report. Acta Cytol. 2008;52:105–8.PubMed
33.
Zurück zum Zitat Hubert JP Jr, Kiernan PD, Beahrs OH, McConahey WM, Woolner LB. Occult papillary carcinoma of the thyroid. Arch Surg. 1980;115:394–8.PubMed Hubert JP Jr, Kiernan PD, Beahrs OH, McConahey WM, Woolner LB. Occult papillary carcinoma of the thyroid. Arch Surg. 1980;115:394–8.PubMed
35.
Zurück zum Zitat Silverberg SG, Vidone RA. Carcinoma of the thyroid in surgical and postmortem material. Analysis of 300 cases at autopsy and literature review. Ann Surg. 1966;164:291–9.PubMedCrossRef Silverberg SG, Vidone RA. Carcinoma of the thyroid in surgical and postmortem material. Analysis of 300 cases at autopsy and literature review. Ann Surg. 1966;164:291–9.PubMedCrossRef
41.
Zurück zum Zitat Autelitano F, Spagnoli LG, Santeusanio G, Villaschi S, Autelitano M. Occult carcinoma of the thyroid gland: an epidemiological study of autopsy material. Ann Ital Chir. 1990;61:141–6.PubMed Autelitano F, Spagnoli LG, Santeusanio G, Villaschi S, Autelitano M. Occult carcinoma of the thyroid gland: an epidemiological study of autopsy material. Ann Ital Chir. 1990;61:141–6.PubMed
45.
Zurück zum Zitat Avetisian IL, Petrova GV. Latent thyroid pathology in residents of Kiev, Ukraine. J Environ Pathol Toxicol Oncol. 1996;15:239–43.PubMed Avetisian IL, Petrova GV. Latent thyroid pathology in residents of Kiev, Ukraine. J Environ Pathol Toxicol Oncol. 1996;15:239–43.PubMed
46.
Zurück zum Zitat Mitselou A, Vougiouklakis T, Peschos D, Dallas P, Agnantis NJ. Occult thyroid carcinoma. A study of 160 autopsy cases. The first report for the region of Epirus-Greece. Anticancer Res. 2002;22:427–32.PubMed Mitselou A, Vougiouklakis T, Peschos D, Dallas P, Agnantis NJ. Occult thyroid carcinoma. A study of 160 autopsy cases. The first report for the region of Epirus-Greece. Anticancer Res. 2002;22:427–32.PubMed
48.
Zurück zum Zitat Jank S, et al. The diagnostic value of ultrasonography to detect occult lymph node involvement at different levels in patients with squamous cell carcinoma in the maxillofacial region. Int J Oral Maxillofac Surg. 2003;32:39–42. doi:10.1054/ijom.2002.0326.CrossRefPubMed Jank S, et al. The diagnostic value of ultrasonography to detect occult lymph node involvement at different levels in patients with squamous cell carcinoma in the maxillofacial region. Int J Oral Maxillofac Surg. 2003;32:39–42. doi:10.​1054/​ijom.​2002.​0326.CrossRefPubMed
50.
Zurück zum Zitat Lin KD, et al. Clinical presentations and predictive variables of thyroid microcarcinoma with distant metastasis. Int Surg. 1997;82:378–81.PubMed Lin KD, et al. Clinical presentations and predictive variables of thyroid microcarcinoma with distant metastasis. Int Surg. 1997;82:378–81.PubMed
54.
Zurück zum Zitat Antonaci A, et al. Survivin and cyclin D1 are jointly expressed in thyroid papillary carcinoma and microcarcinoma. Oncol Rep. 2008;20:63–7.PubMed Antonaci A, et al. Survivin and cyclin D1 are jointly expressed in thyroid papillary carcinoma and microcarcinoma. Oncol Rep. 2008;20:63–7.PubMed
57.
Zurück zum Zitat Londero SC, et al. Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease? Acta Oncol. 2008;47:451–7. doi:10.1080/02841860701630242.CrossRefPubMed Londero SC, et al. Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease? Acta Oncol. 2008;47:451–7. doi:10.​1080/​0284186070163024​2.CrossRefPubMed
58.
Zurück zum Zitat Khoo ML, Ezzat S, Freeman JL, Asa SL. Cyclin D1 protein expression predicts metastatic behavior in thyroid papillary microcarcinomas but is not associated with gene amplification. J Clin Endocrinol Metab. 2002;87:1810–3. doi:10.1210/jc.87.4.1810.CrossRefPubMed Khoo ML, Ezzat S, Freeman JL, Asa SL. Cyclin D1 protein expression predicts metastatic behavior in thyroid papillary microcarcinomas but is not associated with gene amplification. J Clin Endocrinol Metab. 2002;87:1810–3. doi:10.​1210/​jc.​87.​4.​1810.CrossRefPubMed
62.
Zurück zum Zitat Pisanu A, Reccia I, Nardello O, Uccheddu A. Risk factors for nodal metastasis and recurrence among patients with papillary thyroid microcarcinoma: differences in clinical relevance between nonincidental and incidental tumors. World J Surg. 2009;33:460–8. doi:10.1007/s00268-008-9870-8.CrossRefPubMed Pisanu A, Reccia I, Nardello O, Uccheddu A. Risk factors for nodal metastasis and recurrence among patients with papillary thyroid microcarcinoma: differences in clinical relevance between nonincidental and incidental tumors. World J Surg. 2009;33:460–8. doi:10.​1007/​s00268-008-9870-8.CrossRefPubMed
63.
Zurück zum Zitat Jovanovic L, Delahunt B, McIver B, Eberhardt NL, Grebe SK. Most multifocal papillary thyroid carcinomas acquire genetic and morphotype diversity through subclonal evolution following the intra-glandular spread of the initial neoplastic clone. J Pathol. 2008;215:145–54. doi:10.1002/path.2342.CrossRefPubMed Jovanovic L, Delahunt B, McIver B, Eberhardt NL, Grebe SK. Most multifocal papillary thyroid carcinomas acquire genetic and morphotype diversity through subclonal evolution following the intra-glandular spread of the initial neoplastic clone. J Pathol. 2008;215:145–54. doi:10.​1002/​path.​2342.CrossRefPubMed
66.
68.
69.
Zurück zum Zitat Satge D, Grob JC, Pusel J, Methlin G. Thyroid microcarcinoma with a fatal outcome and 34 other unusually aggressive cases reported in the literature. Arch Anat Cytol Pathol. 1990;38:143–51.PubMed Satge D, Grob JC, Pusel J, Methlin G. Thyroid microcarcinoma with a fatal outcome and 34 other unusually aggressive cases reported in the literature. Arch Anat Cytol Pathol. 1990;38:143–51.PubMed
73.
Zurück zum Zitat Avetisian IL, Gulchiy NV, Demidiuk AP, Stashuk AV. Thyroid pathology in residents of the Kiev region, Ukraine, during pre- and post-Chernobyl periods. J Environ Pathol Toxicol Oncol. 1996;15:233–7.PubMed Avetisian IL, Gulchiy NV, Demidiuk AP, Stashuk AV. Thyroid pathology in residents of the Kiev region, Ukraine, during pre- and post-Chernobyl periods. J Environ Pathol Toxicol Oncol. 1996;15:233–7.PubMed
Metadaten
Titel
Increased incidence of papillary thyroid microcarcinoma with decreased tumor size of thyroid cancer
verfasst von
Jen-Der Lin
Publikationsdatum
01.06.2010
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 2/2010
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-009-9242-8

Weitere Artikel der Ausgabe 2/2010

Medical Oncology 2/2010 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.